Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
6.68
+0.06 (0.98%)
Dec 24, 2025, 1:00 PM EST - Market closed
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $155.15 million as of December 24, 2025. Its market cap has decreased by -11.25% in one year.
Market Cap
155.15M
Enterprise Value
135.55M
1-Year Change
-11.25%
Ranking
Category
Stock Price
$6.68
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has increased from $152.13M to $155.15M, an increase of 1.99%. That is a compound annual growth rate of 1.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 153.64M | -1.18% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |